Global Bronchopulmonary Dysplasia Treatment Industry Projected to Reach US$700.2 Million by 2033, Driven by Steady Growth of 6.1% CAGR | FMI

The Global Bronchopulmonary Dysplasia Treatment Industry is on track for significant expansion, with a projected valuation of US$700.2 million by 2033. This represents a substantial increase from its current value of US$385.6 million in 2023. The market is expected to register a consistent Compound Annual Growth Rate (CAGR) of 6.1% throughout the forecast period, reflecting …

Global Bronchopulmonary Dysplasia Treatment Industry Targets US$ 700.2 Million Valuation, Fueled by 6.1% CAGR by 2033 | FMI

The Global Bronchopulmonary Dysplasia Treatment Industry is poised for substantial growth, projected to reach a market value of US$ 700.2 million by the year 2033, as per the latest industry insights. This remarkable expansion is forecasted to be driven by a robust Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period. As of …